top of page
Resources > Articles
Regulatory Intelligence,
In Depth.
Articles, whitepapers, guides, and case studies for Life Sciences regulatory professionals navigating a faster, more complex regulatory world.
Quality


Your Test Lab Is Part of Your Quality System. FDA Keeps Saying So.
Most device quality teams audit their own factories and their critical component suppliers. Fewer apply the same scrutiny to the contract laboratory that generated the bench, biocompatibility, or cybersecurity testing sitting inside a 510(k). FDA has now spent nearly three years telling manufacturers that this is a gap, and the warnings have become more specific. In February 2024, FDA's device center sent a letter to industry describing an increasing number of third-party tes
Nov 67 min read


FDA Told Summit It Needs Overall Survival. The Trial Missed by 0.057. November 14 Will Show How Firm That Line Is.
FDA told Summit it needs statistically significant overall survival. HARMONi missed at p=0.057. Here's what the Nov 14 ivonescimab decision will test.
Nov 46 min read


FDA Read Their Release Notes. Then It Cited Three Software Changes in a Warning Letter.
FDA used release notes and version logs to cite three software changes in a warning letter. Here's what it means for SaMD change control and 510(k) decisions.
Oct 295 min read


Management Review Under QMSR: Why “Top Management” Now Means the CEO
QMSR brings ISO 13485's management responsibility clauses into FDA regulation. What "top management" engagement in management review now requires, and how to show executive accountability that holds up at inspection.
Sep 224 min read
bottom of page